Table 2 Gene profile characteristic of GD patients in comparison to controls and NPC patients.
Comparison | |||
|---|---|---|---|
GD patients vs.cControls | GD patients vs. NPC patients | ||
Genes with Changed Expression | |||
UP-regulated | Fold change | UP-regulated | Fold change |
SERPINB2 | 3,675 | MX1* | 3,139 |
PLAU | 3,242 | TMEM158 | 2,786 |
IL13RA2* | 2,879 | UCHL1 | 2,727 |
IFI6* | 2,769 | ISG15 | 2,637 |
TXNIP | 2,605 | PLAU* | 2,591 |
IFIT2 | 2,568 | FOS | 2,508 |
IFIT1 | 2,555 | MLLT11 | 2,473 |
NPTX1 | 2,473 | IFIT1 | 2,384 |
TMEM158 | 2,457 | PLOD2 | 2,380 |
WLS | 2,362 | IGF2BP3 | 2,256 |
DOWN-regulated | Fold change | DOWN-regulated | Fold change |
IGFBP5 | −4,027 | PTGIS | −3,661 |
CRISPLD2* | −2,689 | ATOH8* | −3,150 |
THBS2 | −2,445 | MXRA5* | −2,926 |
ATOH8* | −2,354 | MN1* | −2,837 |
NNMT | −2,323 | FOXQ1 | −2,743 |
CNN1 | −2,103 | CRIP1 | −2,648 |
ISLR | −2,070 | COMP | −2,573 |
C1QTNF5 | −2,023 | HSPB7 | −2,478 |
CSRP1 | −1,998 | TSHZ2 | −2,414 |
MYLIP | −1,988 | ISLR | −2,250 |